NDC Product
Human Prescription DrugHumalog NDC 50090-1375
- Generic Name
- Insulin Lispro
- Dosage Form
- Injection, Solution
- Route
- Intravenous; Subcutaneous
- Marketing
- BLA
Active Listing
INSULIN LISPRO
UNII GFX7QIS1II
Substance Identification & Data
This profile provides standardized clinical and technical data for Insulin Lispro, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GFX7QIS1II.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 133107-64-9 and the RxNorm Concept ID (RxCUI) 86009. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
INSULIN LISPRO
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
GFX7QIS1II
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
7278
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
EE-77
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Insulin Lispro. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
INSULIN LISPRO
INSULIN LISPRO-AABC
Common Names & Synonyms
28(SUP B)-L-LYSINE-29(SUP B)-L-PROLINEINSULIN (HUMAN)
IDENTICAL TO HUMAN INSULIN EXCEPT FOR THE TRANSPOSITION OF PROLINE AND LYSINE AT POSITIONS 28 AND 29 ON THE B CHAIN
INSULIN (HUMAN), 28(SUP B)-L-LYSINE-29(SUP B)-L-PROLINE-
INSULIN B28(LYS)-B29(PRO) RECOMBINANT HUMAN/PROTAMINE SULPHATE
INSULIN LISPRO (GENETICAL RECOMBINATION)
INSULIN LISPRO (RDNA ORIGIN)
INSULIN LISPRO [EMA EPAR]
INSULIN LISPRO [EP MONOGRAPH]
INSULIN LISPRO [INN]
INSULIN LISPRO [JAN]
INSULIN LISPRO [MI]
INSULIN LISPRO [USAN]
INSULIN LISPRO [USP MONOGRAPH]
INSULIN LISPRO [USP-RS]
INSULIN LISPRO [WHO-DD]
INSULIN LISPRO AABC [WHO-DD]
INSULIN LISPRO PROTAMINE
INSULIN LISPRO PROTAMINE [WHO-DD]
INSULIN LISPRO PROTAMINE RECOMBINANT
INSULIN LISPRO PROTAMINE RECOMBINANT [ORANGE BOOK]
INSULIN LISPRO PROTAMINE SUSPENSION
INSULIN LISPRO RECOMBINANT
INSULIN LISPRO RECOMBINANT [ORANGE BOOK]
INSULIN,LISPRO,HUMAN/RDNA
INSULIN,LISPRO,HUMAN/RDNA [VANDF]
INSULIN,LISPRO,PROTAMINE/RDNA
INSULIN,LISPRO,PROTAMINE/RDNA [VANDF]
LISPRO
LISPRO INSULIN
LISPRO-PH20 COMPONENT INSULIN LISPRO
Brand / Trade Names
ADMELOG
ADMELOG SOLOSTAR
HUMALOG
LYUMJEV
Technical Codes
LY275585
LY-275585
LY900014
LY-900014
SAR342434
SAR-342434
NDC Products Containing INSULIN LISPRO
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
